Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications

Eur Heart J. 2012 Oct;33(19):2399-402. doi: 10.1093/eurheartj/ehs223. Epub 2012 Jul 31.

Abstract

Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.

MeSH terms

  • Acute Kidney Injury / etiology
  • Aortic Valve Insufficiency / etiology
  • Aortic Valve Stenosis / therapy*
  • Arrhythmias, Cardiac / etiology
  • Cardiac Catheterization / adverse effects*
  • Coronary Occlusion / etiology
  • Heart Injuries / etiology
  • Heart Valve Prosthesis / adverse effects*
  • Heart Valve Prosthesis Implantation / adverse effects*
  • Hemorrhage / etiology
  • Humans
  • Randomized Controlled Trials as Topic
  • Stroke / etiology
  • Vascular Diseases / etiology